Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2021, 2021, roč. 16, č. 5, s. 391.